Enteris BioPharma Highlighted as Game Changer in Drug Development & Delivery Special Feature on Innovative Technologies for Improving Drug Solubility and Bioavailability
- Monday, April 4, 2022, 7:04
- Finance
- Add a comment
Article describes unique features of Enteris’ Peptelligence® and ProPerma® peptide and small molecule oral delivery technology BOONTON, N.J., April 4, 2022 /PRNewswire/ — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary…
About the Author
adminasapcorp has written 41283 stories on this site.